The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with other solid tumors: Safety and efficacy results from a phase I study.
 
Xueli Bai
No Relationships to Disclose
 
Qin Xu
No Relationships to Disclose
 
Xinjun Liang
No Relationships to Disclose
 
Qian Chu
No Relationships to Disclose
 
Xiaochen Zhang
No Relationships to Disclose
 
Yiwen Chen
No Relationships to Disclose
 
Nong Xu
Research Funding - MSD (Inst)
 
Weijia Fang
No Relationships to Disclose
 
Jianzhen Shan
No Relationships to Disclose
 
Weiqin Jiang
No Relationships to Disclose
 
Jianya Zhou
No Relationships to Disclose
 
Yu-Long Zheng
No Relationships to Disclose
 
Sixiang Long
Employment - Innovent Biologics (Suzhou) Co., Ltd
 
Haonan Chen
Employment - Innovent Biologics
 
Li Zhao
Employment - Innovent Biologics (Suzhou) Co., Ltd
 
Hongli Wang
Employment - Innovent Biologics (Suzhou) Co., Ltd
 
Jiya Sun
Employment - Innovent Biologics
 
Xing Sun
Employment - Innovent Biologics (Suzhou) Co., Ltd
 
Hui Zhou
Employment - Innovent Biologics (Suzhou) Co., Ltd
 
Tingbo Liang
No Relationships to Disclose